Compare ELOX & NA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELOX | NA |
|---|---|---|
| Founded | 1999 | 2019 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | | Semiconductors |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.3M | 51.9M |
| IPO Year | 2013 | 2021 |
| Metric | ELOX | NA |
|---|---|---|
| Price | $13.20 | $1.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $38.25 | N/A |
| AVG Volume (30 Days) | 17.7K | ★ 20.9K |
| Earning Date | 08-12-2026 | 08-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.00 | $1.58 |
| 52 Week High | $23.40 | $5.16 |
| Indicator | ELOX | NA |
|---|---|---|
| Relative Strength Index (RSI) | 40.05 | 36.72 |
| Support Level | $10.74 | $1.69 |
| Resistance Level | $14.65 | $1.96 |
| Average True Range (ATR) | 1.28 | 0.16 |
| MACD | -0.04 | -0.03 |
| Stochastic Oscillator | 21.89 | 12.46 |
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.
Nano Labs Ltd is a Web 3.0 infrastructure and product solution provider, as well as a crypto treasury company. It is focused on the development of HTC chips and HPC chips. In addition, the company has established BNB value investment and adopted BNB (a crypto token) as the primary reserve asset. Furthermore, it has launched the iPollo Claw, a dedicated hardware solution for the OpenClaw AI Agent Ecosystem. Nano Labs derives revenue mainly from its HTC and HPC offerings, which comprise Darkbird series HPC chips that feature high performance and high energy consumption efficiency, and Cuckoo series chips, used in GPUs. Geographically, the company generates maximum revenue from the People's Republic of China (PRC), and the rest from Singapore, Hong Kong, the United States, and other markets.